Journal of Tissue Engineering and Reconstructive Surgery››2010,Vol. 6››Issue (1): 21-23.doi:10.3969/j.issn.1673-0364.2010.01.006

• Original article •Previous ArticlesNext Articles

The Application of VEGF and bFGF Via Low-Frequency Ultrasound-Mediated Transdermal Drug Transport System in the Improvement of Maximizing Survival of Fascio-Cutaneous flap with Super Length Ratio in Pigs

LU Chuan, TAO Ran, ZHANG Jingde, SONG Jianxing, WANG Xiaoyun, YANG Chao

  1. Corresponding author:YANG Chao. Department of Plastic Surgery; Changhai Hospital Affiliated the Second Military Medical University; Shanghai 200433; China.
  • Published:2020-07-23

Abstract:Objective To explore the effects of single or combined application of VEGF and bFGF via the noninvasive medication of ultrasound-mediated transdermal drug transport(UMTDT) in the survival rate and microcirculation of fasciocutaneous flap with big ratio of length to width.Methods A total of 100 fascio-cutaneous flaps were performed on the sides of the back in ten pigs.The flap area ranged from 3 cm×15 cm.These flaps were randomly divided into 5 groups as follows. A:control group with blank ultrasound;B:VEGF by low-frequency UMTDT;C:bFGF by low-frequency UMTDT;D:VEGF and bFGF by localized injection in multiple points;E:VEGF and bFGF by low-frequency UMTDT.The quantitative analysis of the vitality of the flaps,capillary intensity and expression index were observed 10 days after operation.Results There was significant difference between the group of combined medication of both and bFGF via UMTDT and the other four groups in flap survival rate,capillary intensity and expression index.Conclusion The combined medication of VEGF and bFGF via UMTDT can significantly enhance the survival rate of fascio-cutaneous flaps with big ratio of length to width.

Key words:Vascular endothelial growth factor(VEGF),Basic fibroblast growth factor(bFGF),Low-frequency ultrasound,Transdermal drug delivery,Super long flap,Fascio-cutaneous flap

CLC Number:

Baidu
map